SCHEMBL1022795

SCHEMBL1022795

CC(C)(C)c1ccc([NH])cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.55
LMNA P02545 1/20 0.52
TYR P14679 1/20 0.52
KIF11 P52732 2/20 0.44
ALDH1A1 P00352 4/20 0.42
HPGD P15428 2/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
HDAC1 Q13547 1/20 0.41
SLC22A2 O15244 1/20 0.41
SLC22A1 O15245 1/20 0.41
SLC22A3 O75751 1/20 0.41
BCHE P06276 3/20 0.40
ACHE P22303 3/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
SRD5A2 P31213 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL424728 0.83 TSHR (0.73) TSHRLMNATYRKIF11ALDH1A1
SCHEMBL16241997 0.75 TSHR (0.55) TSHRLMNATYRKIF11ALDH1A1
SCHEMBL807575 0.75 TSHR (0.55) TSHRLMNATYRKIF11ALDH1A1
SCHEMBL67741 0.75 TSHR (0.55) TSHRLMNATYRKIF11ALDH1A1
SCHEMBL1538330 0.73 TSHR (0.61) TSHRLMNATYRKIF11ALDH1A1
SCHEMBL26915 0.73 KIF11 (0.70) TSHRLMNATYRKIF11ALDH1A1
SCHEMBL3423876 0.73 KIF11 (0.70) TSHRLMNATYRKIF11ALDH1A1
SCHEMBL17923896 0.73 TSHR (0.61) TSHRLMNATYRKIF11ALDH1A1
SCHEMBL6524730 0.73 TSHR (0.52) TSHRLMNATYRKIF11ALDH1A1
SCHEMBL6516058 0.73 TSHR (0.52) TSHRLMNATYRKIF11ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114621272-B Boron nitride compound, organic electroluminescent composition and organic electroluminescent device comprising same 季华实验室 2024-03-29 CN claimed
CN-114621271-B Boron nitride compound, organic electroluminescent composition and organic electroluminescent device comprising same 季华实验室 2024-03-29 CN claimed
CN-114621274-B Boron nitride compound, organic electroluminescent composition and organic electroluminescent device comprising same 季华实验室 2024-03-22 CN claimed
CN-114621273-B Boron nitride compound, organic electroluminescent composition and organic electroluminescent device comprising same 季华实验室 2024-03-22 CN claimed
CN-114621273-A Boron-nitrogen compound, organic electroluminescent composition and organic electroluminescent device comprising same 季华实验室 2022-06-14 CN claimed
CN-114621272-A Boron-nitrogen compound, organic electroluminescent composition and organic electroluminescent device comprising same 季华实验室 2022-06-14 CN claimed
CN-114621271-A Boron-nitrogen compound, organic electroluminescent composition and organic electroluminescent device comprising same 季华实验室 2022-06-14 CN claimed
CN-114621274-A Boron-nitrogen compound, organic electroluminescent composition and organic electroluminescent device comprising same 季华实验室 2022-06-14 CN claimed
WO-2020237225-A1 FUNCTIONALIZED GOLD CARBENE NAPHTHOQUINONE COMPLEXES FOR USE IN THE TREATMENT OF CANCER BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2020-11-26 WO claimed
CN-110669058-A Tricyclic quinolone carboxylic acid and preparation method thereof 江西农业大学 2020-01-10 CN claimed
US-6713146-B2 SINGLY RECORDABLE COMPACT DISC (CD-R) BAYER AKTIENGESELLSCHAFT (DE) 2004-03-30 US claimed
US-6562840-B1 Non-peptidic inhibitors of proteolytic enzymes such as urokinase 3-DIMENSIONAL PHARMACEUTICALS, INC. 2003-05-13 US claimed
US-20020172793-A1 Optical data store comprising an axially substituted cobalt phthalocyanine in the light-writeable information layer LANXESS DEUTSCHLAND GMBH (DE) 2002-11-21 US claimed
US-20020127366-A1 Optical data stores containing a Co-phthalocyanine complex in the information layer recordable using light LANXESS DEUTSCHLAND GMBH (DE) 2002-09-12 US claimed
EP-1150979-A1 HETEROARYL AMIDINES, METHYLAMIDINES AND GUANIDINES AS PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2001-11-07 EP claimed
US-20010031781-A1 Heteroaryl amidines, methylamidines and guanidines and use thereof as protease inhibitors ILLIG CARL R (US) 2001-10-18 US claimed
US-6291514-B1 Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors 3-DIMENSIONAL PHARMACEUTICALS, INC. 2001-09-18 US claimed
WO-2000047578-A1 HETEROARYL AMIDINES, METHYLAMIDINES AND GUANIDINES AS PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2000-08-17 WO claimed
EP-0635508-B1 TETRAHYDROPYRIDINE DERIVATIVE HAVING SUBSTITUENTS ON THREE RINGS ASAHI CHEMICAL IND (JP) 1999-10-06 EP claimed
EP-0635508-A1 TETRAHYDROPYRIDINE DERIVATIVE HAVING SUBSTITUENTS ON THREE RINGS Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1995-01-25 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031781-A1 Heteroaryl amidines, methylamidines and guanidines and use thereof as protease inhibitors SERPINE1, PRSS3, PRSS2 TSHR 1131/4885LMNA 850/4885TYR 1566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.